127 related articles for article (PubMed ID: 1723077)
1. Human cytomegalovirus structural proteins: immune reaction against pp150 synthetic peptides.
Landini MP; Ripalti A; Sra K; Pouletty P
J Clin Microbiol; 1991 Sep; 29(9):1868-72. PubMed ID: 1723077
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to synthetic peptides from cytomegalovirus phosphoprotein 150.
Sundqvist VA; Xu W; Wahren B
J Clin Microbiol; 1992 Oct; 30(10):2735-9. PubMed ID: 1328283
[TBL] [Abstract][Full Text] [Related]
3. Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides.
Novák J; Sova P; Krchnák V; Hamsíková E; Závadová H; Roubal J
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1409-13. PubMed ID: 1710650
[TBL] [Abstract][Full Text] [Related]
4. Prokaryotic expression of immunogenic polypeptides of the large phosphoprotein (pp150) of human cytomegalovirus.
Scholl BC; Von Hintzenstern J; Borisch B; Traupe B; Bröker M; Jahn G
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1195-204. PubMed ID: 2455019
[TBL] [Abstract][Full Text] [Related]
5. IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins.
Vornhagen R; Hinderer W; Sonneborn HH; Bein G; Matter L; The TH; Enders G; Jahn G; Plachter B
J Virol Methods; 1996 Jun; 60(1):73-80. PubMed ID: 8795008
[TBL] [Abstract][Full Text] [Related]
6. Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.
Greijer AE; van de Crommert JM; Stevens SJ; Middeldorp JM
J Clin Microbiol; 1999 Jan; 37(1):179-88. PubMed ID: 9854087
[TBL] [Abstract][Full Text] [Related]
7. Different profiles of cytomegalovirus RNA transcripts and anti-cytomegalovirus IgM antibodies in renal transplant recipients.
Goossens VJ; Vink C; Mullers W; Middeldorp JM; Bruggeman CA
J Clin Virol; 2001 Dec; 23(1-2):87-95. PubMed ID: 11595587
[TBL] [Abstract][Full Text] [Related]
8. Epitope analysis of antibodies in Japanese to human cytomegalovirus phosphoprotein 150 with synthetic peptides.
Takahashi I; Sugiura S; Ohta H; Ozawa K; Kamiya T
Biosci Biotechnol Biochem; 2002 Nov; 66(11):2402-5. PubMed ID: 12506979
[TBL] [Abstract][Full Text] [Related]
9. Detection of cytomegalovirus antibodies by an enzyme-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated tegument protein pp150.
Plachter B; Wieczorek L; Scholl BC; Ziegelmaier R; Jahn G
J Clin Microbiol; 1992 Jan; 30(1):201-6. PubMed ID: 1310328
[TBL] [Abstract][Full Text] [Related]
10. Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins.
van Zanten J; Harmsen MC; van der Giessen M; van der Bij W; Prop J; de Leij L; The TH
Clin Diagn Lab Immunol; 1995 Mar; 2(2):214-8. PubMed ID: 7535179
[TBL] [Abstract][Full Text] [Related]
11. Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen.
Xi H; Jinjie L; Shengxiang G; Tingdong L; Han W; Xiaoyi G; Tong-Ming F; Jun Z
J Virol Methods; 2017 Feb; 240():21-25. PubMed ID: 27825854
[TBL] [Abstract][Full Text] [Related]
12. Pattern and persistence of the epitope-specific IgM response against human cytomegalovirus in renal transplant patients.
Müller TF; Gicklhorn D; Jungraithmayr T; Eickmann M; Lange H; Radsak K; Reschke M
J Clin Virol; 2002 Feb; 24(1-2):45-56. PubMed ID: 11744428
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to human cytomegalovirus structural polypeptides during primary infection.
Landini MP; Rossier E; Schmitz H
J Virol Methods; 1988 Dec; 22(2-3):309-17. PubMed ID: 2851606
[TBL] [Abstract][Full Text] [Related]
14. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens.
Weber B; Fall EM; Berger A; Doerr HW
J Clin Virol; 1999 Dec; 14(3):173-81. PubMed ID: 10614854
[TBL] [Abstract][Full Text] [Related]
15. Characterization of host immunity to cytomegalovirus pp150 (UL32).
La Rosa C; Wang Z; Lacey SF; Markel SF; Sharma MC; Martinez J; Lalimarmo MM; Diamond DJ
Hum Immunol; 2005 Feb; 66(2):116-26. PubMed ID: 15694996
[TBL] [Abstract][Full Text] [Related]
16. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
[TBL] [Abstract][Full Text] [Related]
17. Highly acidic C-terminal region of cytomegalovirus pUL96 determines its functions during virus maturation independently of a direct pp150 interaction.
Brechtel TM; Mocarski ES; Tandon R
J Virol; 2014 Apr; 88(8):4493-503. PubMed ID: 24501413
[TBL] [Abstract][Full Text] [Related]
18. Elimination of nonspecific cytomegalovirus immunoglobulin M activities in the enzyme-linked immunosorbent assay by using anti-human immunoglobulin G.
Joassin L; Reginster M
J Clin Microbiol; 1986 Mar; 23(3):576-81. PubMed ID: 3007570
[TBL] [Abstract][Full Text] [Related]
19. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies.
Busse C; Strubel A; Schnitzler P
J Clin Virol; 2008 Oct; 43(2):137-41. PubMed ID: 18621576
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus matrix protein PP150 is efficiently presented as one of target antigens for cytotoxic T lymphocyte recognition.
Li C; Yang X; Tu W; Riddell SR
Chin Med J (Engl); 1997 May; 110(5):397-400. PubMed ID: 9594311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]